Angel Invests - News Details

iRxReminder in the News

Angel Invests

Angel Invests
Mar 6, 2014

Akron, Ohio (March 6, 2014) – iRxReminder, LLC has received a $250,000 commitment in seed funding from an undisclosed Washington, DC-based angel investment group for the further development and promotion of the company’s technology and healthcare patient management system. The company has raised $458,000 to date. iRxReminder will receive dispersements upon completion of specific milestones including the completion of novel add-on technology and FDA submission.

“We are confident in the ability of iRxReminder’s management to execute the company’s business plan to support improved health outcomes and health research through the iRxReminder suite of products”, stated a representative for the investors. The DC group has extensive experience in operating small to medium size technology companies, raising capital and adding shareholder value.

“Mobile technology solutions will accelerate the vital and needed change in our healthcare delivery system. Our system leads to activated patients, comprehensive real-time care, and for our customers, better outcomes with significantly reduced costs,” said Anthony Sterns, iRxReminder’s CEO. “Our system is at the forefront of these changes and this funding provides the needed capital for us to broadly promote our system with researchers in the near term. We are also seeking early adopters in accountable care organizations, integrated delivery networks and payers who want to reap the early benefits of our unique mobile healthcare management technology.”

About iRxReminder, LLC.
iRxReminder is an Akron, Ohio-based mobile health application service provider focused on real-
time medication adherence, care compliance, patient activation and data capture in disease, medicine, device or behavior-based care provision or research. The iRxReminder app, available in the Apple App Store, is a customizable, bidirectional tool that is used to conduct patient care management or intervention studies of individuals with complex chronic conditions, such as cancer, autoimmune disorders, diabetes, pulmonary and heart disease among others. The company has completed projects with or currently has projects in progress with such institutions as Case Western Reserve University, Kent State University, University of Wisconsin School of Medicine and Summa Health System. The company plans to evolve with FDA approval of the iLid, their automated dispensing and verification medication dispensing system as a medical device and a complete patient-centered clinical management and education system supporting accountable care and population health management goals. The iRxReminder system meets healthcare’s pressing need for real-time data capture, care control, patient compliance and clinician and patient coordination to produce better outcomes and reduce costs. For more information, visit or contact Larry Tusick, Vice President of Business Development.